The translation industry is undergoing a profound and rapid transformation. Until just a few years ago, translation was seen as a fairly linear process—reading the source text, translating it, reviewing it, and delivering the final version. Today, however, the landscape is significantly broader and more dynamic. The introduction of Artificial Intelligence (AI) has opened entirely […]
Every press release tells a story. Whether it’s about the launch of a new product, a strategic partnership, or a major corporate milestone, the goal is always the same: to communicate clearly, consistently, and persuasively. But when that message needs to cross linguistic borders, there’s a real risk of losing its impact and direction. Translating […]
Companies looking to make their mark—and not get lost—in the vast digital ocean of search engines have a powerful ally: SEO translation. This process can transform translated texts into high-quality content that search engines are more likely to display to a global audience. Let’s explore the concept of SEO and its primary goal: The goal […]
Patent litigation is a fundamental legal discipline in the field of intellectual property, especially for companies that innovate and want to protect their creations. In this context, legal translation plays a crucial role. While patent litigation primarily involves the defense of exclusive rights related to a patent, globalization has increasingly led to disputes that cross […]
At Aglatech14, we believe that a company’s value is not measured solely in numbers but in the tangible impact it creates in society. For this reason, in 2025, we launched an innovative social project based on inclusion, sustainability, and corporate responsibility. Our approach goes beyond simple donations: we actively participate in change, collaborating with organizations […]
The EU Regulation 2024/1860, published in the Official Journal of the European Union on July 9, 2024, introduces significant amendments to Regulations (EU) 2017/745 and 2017/746. These amendments include new provisions for the use of the European Database on Medical Devices (EUDAMED) and additional obligations for manufacturers, as explained by Alessandra Basilisco, Biomedical Engineer, Office […]
Italy has stood out as one of the first European countries to recognize the need to postpone certain deadlines set by the Medical Device Regulation (MDR), thus averting the risk of shortages of essential devices for the European healthcare system. According to Dr. Iachino, Director General of Medical Devices and Pharmaceutical Services at the Ministry […]
The integration of procurement and Health Technology Assessment (HTA) is a crucial step toward making purchasing processes more effective and value-based. This was emphasized by Guido Gastaldon, Head of the Healthcare, Goods, and Services Sourcing Division at Consip, during the AboutMedicalDevices conference. This approach is transforming public tenders, particularly in healthcare, making Health Technology Assessment […]
Health Technology Assessment (HTA) in Italy is a multidisciplinary process that synthesizes information on clinical, economic, social, and ethical aspects related to the use of a health technology in a systematic, transparent, unbiased, and robust way. The goal of HTA is to support the definition of safe, effective, and patient-centred health policies, ensuring maximum value […]
With the enforcement of the European Medical Devices Regulation (MDR), clinical evidence has become a cornerstone for regulatory compliance, as highlighted by Pietro Calamea, Director of Office VI – Clinical Investigation of Medical Devices, Directorate General of Medical Devices and Pharmaceutical Services, Ministry of Health, during the AboutMedicalDevices conference. However, contrary to expectations, there has […]
